KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening
Milestone affirms KBI and Selexis SA’s Geneva cGMP site is operational and running successfully. GENEVA, March 21, 2023 – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced that late in 2022, it successfully released its...
Read More